Urinary Extracellular Vesicles as Biomarkers of Kidney Disease: From Diagnostics to Therapeutics release_brwvhjdbwrc3xix2pyp37iagle

by In O Sun, Lilach O. Lerman

Published in Diagnostics by MDPI AG.

2020   Volume 10, Issue 5, p311

Abstract

Cell-derived extracellular vesicles (EVs) can be isolated from various body fluids, including urine. Urinary EVs have gained important recognition as potential diagnostic biomarkers in renal disease since their cargo includes nucleic acids, proteins, and other cellular components, which likely mirror the physiological and possibly pathophysiological state of cells along the nephron. Accumulating evidence highlights the feasibility of using EVs as biomarkers for diagnostic, prognostic, and therapeutic purposes in several forms of renal disease, such as acute kidney injury, glomerulonephritis, and renal transplantation. Additionally, exogenous delivery of EVs released in vitro by cells in culture may have salutary benefits for renal diseases. In this review, we introduce recent studies that attempt to identify urinary EVs as candidate biomarkers for human kidney diseases and consider their potential implication as a therapeutic option in key kidney diseases.
In application/xml+jats format

Archived Files and Locations

application/pdf  598.5 kB
file_5ifiqcdu3zhsbjscqlysgvxlg4
res.mdpi.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-05-16
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  2075-4418
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: ba324d08-1d43-4752-8da9-8392ceeee1af
API URL: JSON